Related references
Note: Only part of the references are listed.Emerging roles and mechanisms of FOXC2 in cancer
Teng Wang et al.
CLINICA CHIMICA ACTA (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC
Darina Lazarova et al.
JOURNAL OF CANCER (2017)
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2
Chun-Lin Zhang et al.
CANCER LETTERS (2017)
Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression
Wei Jiang et al.
BMC CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
D. A. Fennell et al.
CANCER TREATMENT REVIEWS (2016)
Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo
Chanjuan Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
A. N. Paranjape et al.
ONCOGENE (2016)
Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast
Jeffrey Chun Tatt Lim et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition
Zhijiao Zhou et al.
CANCER LETTERS (2015)
FOXF2 suppresses the FOXC2-mediated epithelial mesenchymal transition and multidrug resistance of basal-like breast cancer
Jun Cai et al.
CANCER LETTERS (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
被撤回的出版物: FOXC2 promotes colorectal cancer metastasis by directly targeting MET (Retracted article. See vol. 41, pg. 2529, 2022)
Y-M Cui et al.
ONCOGENE (2015)
FOXC2 promotes colorectal cancer proliferation through inhibition of FOX03a and activation of MAPK and AKT signaling pathways
Yan-Mei Cui et al.
CANCER LETTERS (2014)
Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells
Zong-cai Liu et al.
CELL AND TISSUE RESEARCH (2014)
SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell
Hao Liu et al.
CELLULAR SIGNALLING (2014)
Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway
Hao Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies
Hua Sui et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer
Brett G. Hollier et al.
CANCER RESEARCH (2013)
Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line
Jin Ren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol
Y-H Yu et al.
ONCOGENE (2013)
Epithelial-Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer
Hao Wang et al.
PLOS ONE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
Alexandria M. Haslehurst et al.
BMC CANCER (2012)
Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non-Small-Cell Lung Cancer After Curative Resection
Wei Jiang et al.
CLINICAL LUNG CANCER (2012)
Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
Fariz Nurwidya et al.
CANCER RESEARCH AND TREATMENT (2012)
Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
Laura Rosano et al.
CLINICAL CANCER RESEARCH (2011)
Gene Expression of Mesenchyme Forkhead 1 (FOXC2) Significantly Correlates With the Degree of Lymph Node Metastasis in Colorectal Cancer
Toshiaki Watanabe et al.
INTERNATIONAL SURGERY (2011)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
Sendurai A. Mani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells
XH Wang et al.
ONCOGENE (2004)
Share Paper
